Recent progress in genetic variants associated with cancer and their implications in diagnostics development

References

• Dimas AS, Dermitzakis ET. Genetic variation of regulatory systems. Curr. Opin. Genet. Dev.1(6), 586–590 (2009).
   Google Scholar
• Ku CS, Chia KS. The success of the genome-wide association approach: a brief story of a long struggle. Eur. J. Hum. Genet.16(5), 554–564 (2008).
   PubMedGoogle Scholar
• Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61, 437–455 (2010).
   PubMed Web of Science ®Google Scholar
• Wain LV, Armour JA, Tobin MD. Genomic copy number variation, human health, and disease.Lancet374(9686), 340–350 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang F, Gu W, Hurles ME et al. Copy number variation in human health, disease, and evolution. Annu. Rev. Genomics Hum. Genet.10, 451–481 (2009).
   PubMed Web of Science ®Google Scholar
• Shlien A, Tabori U, Marshall CR et al. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc. Natl Acad. Sci. USA105(32), 11264–11269 (2008).
   PubMed Web of Science ®Google Scholar
• Dear PH. Copy-number variation: the end of the human genome? Trends Biotechnol.27(8), 448–454 (2009).
   PubMed Web of Science ®Google Scholar
• Wu X, Hildebrandt MA, Chang DW. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications. Cancer Metastasis Rev.28(3–4), 269–280 (2009).
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Castaldi P, Evangelou E. A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J. Natl Cancer Inst.102(12), 846–858 (2010).
   PubMedGoogle Scholar
• Yeager M, Orr N, Hayes RB et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet.39(5),645–649 (2007).
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Manolescu A et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet.39(5), 631–637 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas G, Jacobs KB, Year M et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet.40(3), 310–315 (2008).
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Rafnar T et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet. 40(3), 281–283 (2008).
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Gudbjartsson DF et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet. 41(10), 1122–1126 (2009).
   PubMedGoogle Scholar
• Hunter DJ, Kraft P, Jacobs KB et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet.39(7), 870–874 (2007).
   PubMed Web of Science ®Google Scholar
• Stacey SN, Manolescu A, Sulem P et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet.39(7), 865–869 (2007).
   PubMed Web of Science ®Google Scholar
• Stacey SN, Manolescu A, Sulem P et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet.40(6), 703–706 (2008).
   PubMed Web of Science ®Google Scholar
• Zheng W, Long J, Gao YT et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet.41(3), 324–328 (2009).
   PubMed Web of Science ®Google Scholar
• Thomas G, Jacobs KB, Kraft P et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 41(5), 579–584 (2009).
   PubMed Web of Science ®Google Scholar
• Ahmed S, Thomas G, Ghoussaini M et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet.41(5), 585–590 (2009).
   PubMed Web of Science ®Google Scholar
• Turnbull C, Ahmed S, Morrison J et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet.42(6), 504–507 (2010).
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Webb E, Carvajal-Carmona L et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet.39(8), 984–988 (2007).
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Webb E, Carvajal-Carmona L et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet.40(5), 623–630 (2008).
   PubMed Web of Science ®Google Scholar
• Tenesa A, Farrington SM, Prendergast JG et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet.40(5), 631–637 (2008).
   PubMed Web of Science ®Google Scholar
• Sakamoto H, Yoshimura K, Saeki N et al.; Study Group of Millennium Genome Project for Cancer. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat. Genet.40(6), 730–740 (2008).
   PubMed Web of Science ®Google Scholar
• Papaemmanuil E, Hosking FJ, Vijayakrishnan J et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat. Genet.41(9), 1006–1010 (2009).
   PubMed Web of Science ®Google Scholar
• Di Bernardo MC, Crowther-Swanepoel D, Broderick P et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet.40(10), 1204–1210 (2008).
   PubMed Web of Science ®Google Scholar
• Crowther-Swanepoel D, Broderick P, Di Bernardo MC et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat. Genet.42(2), 132–136 (2010).
   PubMed Web of Science ®Google Scholar
• Brown KM, Macgregor S, Montgomery GW et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet.40(7), 838–840 (2008).
   PubMed Web of Science ®Google Scholar
• Bishop DT, Demenais F, Iles MM et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet.41(8), 920–925 (2009).
   PubMed Web of Science ®Google Scholar
• Stacey SN, Gudbjartsson DF, Sulem P et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits.Nat. Genet. 40(11), 1313–1318 (2008).
   PubMed Web of Science ®Google Scholar
• Stacey SN, Sulem P, Masson G et al. New common variants affecting susceptibility to basal cell carcinoma.Nat. Genet.41(8), 909–914 (2009).
   PubMedGoogle Scholar
• Amos CI, Wu X, Broderick P et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet.40(5), 616–622 (2008).
   PubMed Web of Science ®Google Scholar
• McKay JD, Hung RJ, Gaborieau V et al. Lung cancer susceptibility locus at 5p15.33. Nat. Genet.40(12), 1404–1406 (2008).
   PubMed Web of Science ®Google Scholar
• Wang Y, Broderick P, Webb E et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet.40(12), 1407–1409 (2008).
   PubMed Web of Science ®Google Scholar
• Sholl LM, Yeap BY, Iafrate AJ et al. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers. Cancer Res.69(21), 8341–8348 (2009).
   PubMedGoogle Scholar
• Soh J, Toyooka S, Ichihara S et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J. Thorac. Oncol.3(4), 340–347 (2008).
   PubMed Web of Science ®Google Scholar
• Tang X, Varella-Garcia M, Xavier AC et al. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas. Cancer Prev. Res. (Phila. PA)1(3), 192–200 (2008).
   PubMedGoogle Scholar
• Yatabe Y, Takahashi T, Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res.68(7), 2106–2111 (2008).
   PubMed Web of Science ®Google Scholar
• Capasso M, Devoto M, Hou C et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat. Genet.41(6), 718–723 (2009).
   PubMed Web of Science ®Google Scholar
• Wrensch M, Jenkins RB, Chang JS et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 41(8), 905–908 (2009).
   PubMed Web of Science ®Google Scholar
• Amundadottir L, Kraft P, Stolzenberg-Solomon RZ et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet.41(9), 986–990 (2009).
   PubMed Web of Science ®Google Scholar
• Petersen GM, Amundadottir L, Fuchs CS et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet.42(3), 224–228 (2010).
   PubMed Web of Science ®Google Scholar
• Bei JX, Li Y, Jia WH et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet.42(7), 599–603 (2010).
   PubMedGoogle Scholar
• Cho WC. MicroRNAs in cancer – from research to therapy. Biochim. Biophys. Acta 1805(2), 209–217 (2010).
   Google Scholar
• Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol.42(8), 1273–1281 (2010).
   PubMed Web of Science ®Google Scholar
• Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn.10(3), 297–308 (2010).
   PubMed Web of Science ®Google Scholar
• Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet.24(10), 489–497 (2008).
   PubMed Web of Science ®Google Scholar
• Cho WC. Role of miRNAs in lung cancer. Expert Rev. Mol. Diagn.9(8), 773–776 (2009).
   PubMed Web of Science ®Google Scholar
• Chin LJ, Ratner E, Leng S et al. A SNP in a let-7 microRNA complementary site in the KRAS 3´ untranslated region increases non-small cell lung cancer risk. Cancer Res.68(20), 8535–8540 (2008).
   PubMed Web of Science ®Google Scholar
• Tchatchou S, Jung A, Hemminki K et al. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis30(1), 59–64 (2009).
   PubMedGoogle Scholar
• Christensen BC, Whiting MA, Ouellet LG et al. Mature miRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.Clin. Cancer Res.16(14), 3713–3720 (2010).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature461(7265), 747–753 (2009).
   PubMed Web of Science ®Google Scholar
• Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet.11(6), 415–425 (2010).
   PubMed Web of Science ®Google Scholar
• Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet.24(3), 133–141 (2008).
   PubMed Web of Science ®Google Scholar
• Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet.26(3), 132–141 (2010).
   PubMedGoogle Scholar
• Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat. Rev. Cancer10(5), 353–361 (2010).
   PubMed Web of Science ®Google Scholar
• Cho WC. Omics approaches in cancer research. In: An Omics Perspective on Cancer Research. Cho WC (Ed.). Springer, Berlin, Germany 1–9 (2010).
   Google Scholar
• Cho WC. Conquering cancer through discovery research. IUBMB Life62(9), 646–650 (2010).
   Google Scholar